Tower Research Capital (TRC)’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-10,834
| Closed | -$4.01K | – | 6413 |
|
2023
Q3 | $4.01K | Buy |
10,834
+276
| +3% | +$102 | ﹤0.01% | 4932 |
|
2023
Q2 | $12.4K | Buy |
10,558
+9,010
| +582% | +$10.5K | ﹤0.01% | 3855 |
|
2023
Q1 | $3K | Buy |
1,548
+1,247
| +414% | +$2.42K | ﹤0.01% | 5298 |
|
2022
Q4 | $1K | Buy |
301
+137
| +84% | +$455 | ﹤0.01% | 5813 |
|
2022
Q3 | $2K | Sell |
164
-12
| -7% | -$146 | ﹤0.01% | 5717 |
|
2022
Q2 | $6K | Buy |
176
+112
| +175% | +$3.82K | ﹤0.01% | 5021 |
|
2022
Q1 | $4K | Buy |
64
+28
| +78% | +$1.75K | ﹤0.01% | 5334 |
|
2021
Q4 | $11K | Buy |
36
+23
| +177% | +$7.03K | ﹤0.01% | 4524 |
|
2021
Q3 | $10K | Buy |
+13
| New | +$10K | ﹤0.01% | 4392 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 6182 |
|
2021
Q1 | – | Sell |
-1
| Closed | -$1K | – | 5946 |
|
2020
Q4 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 5078 |
|
2020
Q3 | – | Sell |
-1
| Closed | -$6K | – | 5259 |
|
2020
Q2 | $6K | Sell |
1
-1
| -50% | -$6K | ﹤0.01% | 4247 |
|
2020
Q1 | $8K | Buy |
2
+1
| +100% | +$4K | ﹤0.01% | 2154 |
|
2019
Q4 | $6K | Buy |
+1
| New | +$6K | ﹤0.01% | 2648 |
|